Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 (Phenylimino) 1,3 thiazolidin 4 one Sulfoxide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116981659A details a novel Fe-catalyzed route for chiral sulfoxides, offering high purity and cost reduction in pharmaceutical intermediate manufacturing without chiral HPLC.